102 related articles for article (PubMed ID: 21888455)
1. Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation.
Foroutan B; Zitzelsberger H; Bauer V; Ruf AA; Baumgartner A; Anderson D
Arch Iran Med; 2011 Sep; 14(5):321-6. PubMed ID: 21888455
[TBL] [Abstract][Full Text] [Related]
2. An in vitro model to study chemoresistance in non-Hodgkin's lymphoma patients over-expressing mutant p53.
Foroutan B; Ruf AA; Costall B; Anderson D
J Pharmacol Toxicol Methods; 2007; 55(2):151-8. PubMed ID: 16870476
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of DNA damage and its repair in cells from NHL patients with different p53 mutant protein status, resistant (p53(+)) and sensitive (p53(-)) to cancer chemotherapy.
Foroutan B; Ali Ruf A; Jerwood D; Anderson D
J Pharmacol Toxicol Methods; 2007; 55(1):58-64. PubMed ID: 16624596
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light chain gene translocations in non-Hodgkin's lymphoma as assessed by fluorescence in situ hybridisation.
Fujimoto Y; Nomura K; Fukada S; Shimizu D; Shimura K; Matsumoto Y; Horiike S; Nishida K; Shimazaki C; Abe M; Taniwaki M
Eur J Haematol; 2008 Feb; 80(2):143-50. PubMed ID: 18005388
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
Maxwell SA; Mousavi-Fard S
Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study.
García JL; Hernandez JM; Gutiérrez NC; Flores T; González D; Calasanz MJ; Martínez-Climent JA; Piris MA; Lopéz-Capitán C; González MB; Odero MD; San Miguel JF
Leukemia; 2003 Oct; 17(10):2016-24. PubMed ID: 14513052
[TBL] [Abstract][Full Text] [Related]
7. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.
Podolski-Renić A; Jadranin M; Stanković T; Banković J; Stojković S; Chiourea M; Aljančić I; Vajs V; Tešević V; Ruždijić S; Gagos S; Tanić N; Pešić M
Cancer Chemother Pharmacol; 2013 Sep; 72(3):683-97. PubMed ID: 23934261
[TBL] [Abstract][Full Text] [Related]
10. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
[TBL] [Abstract][Full Text] [Related]
11. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
[TBL] [Abstract][Full Text] [Related]
12. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.
Yen CC; Chen YJ; Lu KH; Hsia JY; Chen JT; Hu CP; Chen PM; Liu JH; Chiou TJ; Wang WS; Yang MH; Chao TC; Lin CH
Int J Oncol; 2003 Oct; 23(4):871-81. PubMed ID: 12963965
[TBL] [Abstract][Full Text] [Related]
13. Identification of loss of p16 expression and upregulation of MDR-1 as genetic events resulting from two novel chromosomal translocations found in a plasmablastic lymphoma of the uterus.
Matsuki E; Miyakawa Y; Asakawa S; Tsukada Y; Yamada T; Yokoyama K; Kudoh J; Ikeda Y; Okamoto S
Clin Cancer Res; 2011 Apr; 17(8):2101-9. PubMed ID: 21325069
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization.
Bentz M; Döhner H; Werner CA; Huck K; Baudis M; Joos S; Schlegelberger B; Trümper LH; Feller AC; Pfreundschuh M
Stem Cells; 1995 Dec; 13 Suppl 3():83-7. PubMed ID: 8747993
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
[TBL] [Abstract][Full Text] [Related]
16. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
17. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ
Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758
[TBL] [Abstract][Full Text] [Related]
18. Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma.
Krämer A; Schweizer S; Neben K; Giesecke C; Kalla J; Katzenberger T; Benner A; Müller-Hermelink HK; Ho AD; Ott G
Leukemia; 2003 Nov; 17(11):2207-13. PubMed ID: 14523473
[TBL] [Abstract][Full Text] [Related]
19. MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma.
Sun RX; Coste J; Segara C; Rousset T; Fabbro M; Rème T; Legouffe E; Klein B; Rossi JF
Clin Lab Haematol; 1998 Apr; 20(2):87-94. PubMed ID: 9681218
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
Hosny G; Farahat N; Hainaut P
Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
